Learning and memory impairments in a congenic C57BL/6 strain of mice that lacks the M2 muscarinic acetylcholine receptor subtype

Behavioural Brain Research

Volumn 190, Issue 1, 2008, Pages 50-58

  Bainbridge, Natalie K ^a   Koselke, Lisa R ^a   Jeon, Jongrye ^b   Bailey, Kathleen R ^c   Wess, Jürgen ^b   Crawley, Jacqueline N ^c   Wrenn, Craige C ^a  

^a DRAKE UNIVERSITY   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^c NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

Acetylcholine; Habituation; Holeboard; Knockout; M2; Memory; Muscarinic; Passive avoidance

Indexed keywords

ACETYLCHOLINE; MUSCARINIC M2 RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONDITIONING; CONGENIC STRAIN; CONTROLLED STUDY; FEMALE; GENE MUTATION; GENOTYPE; HABITUATION; LEARNING DISORDER; MALE; MEMORY DISORDER; MOUSE; NONHUMAN; NULL ALLELE; OPEN FIELD TEST; PASSIVE AVOIDANCE; PRIORITY JOURNAL; WILD TYPE;

ANALYSIS OF VARIANCE; ANIMALS; AVOIDANCE LEARNING; BEHAVIOR, ANIMAL; CONDITIONING (PSYCHOLOGY); EXPLORATORY BEHAVIOR; FEAR; FEMALE; HABITUATION, PSYCHOPHYSIOLOGIC; LEARNING DISORDERS; MALE; MEMORY DISORDERS; MEMORY, SHORT-TERM; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTOR, MUSCARINIC M2; SEX FACTORS; SPATIAL BEHAVIOR;

EID: 41949137658     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbr.2008.02.001     Document Type: Article

References (55)

1. Acquas E., Wilson C., and Fibiger H.C. Conditioned and unconditioned stimuli increase frontal cortical and hippocampal acetylcholine release: effects of novelty, habituation, and fear. J Neurosci 16 (1996) 3089-3096
2. Anagnostaras S.G., Murphy G.G., Hamilton S.E., Mitchell S.L., Rahnama N.P., Nathanson N.M., et al. Selective cognitive dysfunction in acetylcholine m-1 muscarinic receptor mutant mice. Nat Neurosci 6 (2003) 51-58
3. Banbury Conference on Genetic Background in Mice. Mutant mice and neuroscience: recommendations concerning genetic background. Neuron 1997;19:755-759.
4. Bartus R., Dean III R., Beer B., and Lippa A. The cholinergic hypothesis of geriatric memory dysfunction. Science 217 (1982) 408-414
5. Bolivar V.J., Cook M.N., and Flaherty L. Mapping of quantitative trait loci with knockout/congenic strains. Genome Res 11 (2001) 1549-1552
6. 3H]quinuclidinylbenzilate binding to rat brain membranes. Mol Pharmacol 30 (1986) 58-68
7. Carey G.J., Billard W., Binch I., Herbert, Cohen-Williams M., Crosby G., et al. SCH 57790, a selective muscarinic m2 receptor antagonist, releases acetylcholine and produces cognitive enhancement in laboratory animals. Eur J Pharmacol 431 (2001) 189-200
8. Caulfield M.P. Muscarinic receptors-characterization, coupling and function. Pharmacol Ther 58 (1993) 319-379
9. Caulfield M.P., and Birdsall N.J.M. International union of pharmacology. XVII. Classification of muscarinic acetylcholine receptors. Pharmacol Rev 50 (1998) 279-290
10. Coyle J., Price D., and DeLong M. Alzheimer's disease: a disorder of cortical cholinergic innervation. Science 219 (1983) 1184-1190
11. Crawley J.N., and Paylor R. A proposed test battery and constellations of specific behavioral paradigms to investigate the behavioral phenotypes of transgenic and knockout mice. Horm Behav 31 (1997) 197-211
12. Crusio W.E. Flanking gene and genetic background problems in genetically manipulated mice. Biol Psychiatry 56 (2004) 381-385
13. Day J., Damsma G., and Fibiger H.C. Cholinergic activity in the rat hippocampus, cortex and striatum correlates with locomotor activity: an in vivo microdialysis study. Pharmacol Biochem Behav 38 (1991) 723-729
14. Degroot A., Salhoff C., Davies R.J., and Nomikos G.G. Genetic deletion of CB1 receptors improves non-associative learning. Behav Brain Res 162 (2005) 161-164
15. Doods H., Entzeroth M., Ziegler H., Schiavi G., Engel W., Mihm G., et al. Characterization of BIBN 99: a lipophilic and selective muscarinic m2 receptor antagonist. Euro J Pharmacol 242 (1993) 23-30
16. Dorje F., Wess J., Lambrecht G., Tacke R., Mutschler E., and Brann M. Antagonist binding profiles of five cloned human muscarinic receptor subtypes. J Pharmacol Exp Ther 256 (1991) 727-733
17. Freund T.F., and Gulyas A.I. Inhibitory control of GABAergic interneurons in the hippocampus. Can J Physiol Pharmacol 75 (1997) 479-487
18. Gerlai R. Gene-targeting studies of mammalian behavior: is it the mutation or the background genotype?. Trends Neurosci 19 (1996) 177-181
19. Gomeza J., Shannon H., Kostenis E., Felder C., Zhang L., Brodkin J., et al. Pronounced pharmacologic deficits in m2 muscarinic acetylcholine receptor knockout mice. Proc Natl Acad Sci USA 96 (1999) 1692-1697
20. Gomeza J., Zhang L., Kostenis E., Felder C., Bymaster F., Brodkin J., et al. Enhancement of D1 dopamine receptor-mediated locomotor stimulation in M4 muscarinic acetylcholine receptor knockout mice. Proc Natl Acad Sci USA 96 (1999) 10483-10488
21. Hajos N., Papp E.C., Acsady L., Levey A.I., and Freund T.F. Distinct interneuron types express m2 muscarinic receptor immunoreactivity on their dendrites or axon terminals in the hippocampus. Neuroscience 82 (1997) 355-376
22. Hammer R., Giraldo E., Schiavi G.B., Monferini E., and Ladinsky H. Binding profile of a novel cardioselective muscarine receptor antagonist, AF-DX 116, to membranes of peripheral tissues and brain in the rat. Life Sci 38 (1986) 1653-1662
23. Holmes A., Murphy D.L., and Crawley J.N. Abnormal behavioral phenotypes of serotonin transporter knockout mice: parallels with human anxiety and depression. Biol Psychiatry 54 (2003) 953-959
24. Inglis F.M., and Fibiger H.C. Increases in hippocampal and frontal cortical acetylcholine release associated with presentation of sensory stimuli. Neuroscience 66 (1995) 81-86
25. Ishii M., and Kurachi Y. Muscarinic acetylcholine receptors. Curr Pharm Des 12 (2006) 3573-3581
26. Iversen S.D. Behavioural evaluation of cholinergic drugs. Life Sci 60 (1997) 1145-1152
27. Kuc K.A., Gregersen B.M., Gannon K.S., and Dodart J.-C. Holeboard discrimination learning in mice. Genes Brain Behav 5 (2006) 355-363
28. Lachowicz J.E., Duffy R.A., Ruperto V., Kozlowski J., Zhou G.W., Clader J., et al. Facilitation of acetylcholine release and improvement in cognition by a selective M-2 muscarinic antagonist, SCH 72788. Life Sci 68 (2001) 2585-2592
29. Lachowicz J.E., Lowe D., Duffy R.A., Ruperto V., Taylor L.A., Guzik H., et al. SCH 57790: a novel m2 receptor selective antagonist. Life Sci 64 (1999) 535-539
30. Levey A.I. Immunological localization of m1-m5 muscarinic acetylcholine receptors in peripheral tissues and brain. Life Sci 52 (1993) 441-448
31. Levey A.I., Edmunds S.M., Hersch S.M., Wiley R.G., and Heilman C.J. Light and electronic microscopic study of m2 muscarinic acetylcholine receptor in the basal forebrain of the rat. J Comp Neurol 351 (1995) 339-356
32. Michel A.D., and Whiting R.L. Methoctramine, a polymethylene tetraamine, differentiates three subtypes of muscarinic receptor in direct binding studies. Eur J Pharmacol 145 (1988) 61-66
33. Miyakawa T., Yamada M., Duttaroy A., and Wess J. Hyperactivity and intact hippocampus-dependent learning in mice lacking the m-1 muscarinic acetylcholine receptor. J Neurosci 21 (2001) 5239-5250
34. Moore H., Sarter M., and Bruno J.P. Age-dependent modulation of in vivo cortical acetylcholine release by benzodiazepine receptor ligands. Brain Res 596 (1992) 17-29
35. Moore H., Sarter M., and Bruno J.P. Bidirectional modulation of stimulated cortical acetylcholine release by benzodiazepine receptor ligands. Brain Res 627 (1993) 267-274
36. Quirion R., Wilson A., Rowe W., Aubert I., Richard J., Doods H., et al. Facilitation of acetylcholine release and cognitive performance by an m(2)-muscarinic receptor antagonist in aged memory-impaired. J Neurosci 15 (1995) 1455-1462
37. Rowe W.B., O'Donnell J.P., Pearson D., Rose G.M., Meaney M.J., and Quirion R. Long-term effects of BIBN-99, a selective muscarinic m2 receptor antagonist, on improving spatial memory performance in aged cognitively impaired rats. Behav Brain Res 145 (2003) 171-178
38. Roy I.L., Pothion S., Mortaud S., Chabert C., Nicolas L., Cherfouh A., et al. Loss of aggression, after transfer onto a C57BL/6J background, in mice carrying a targeted disruption on the neuronal nitric oxide synthase gene. Behav Genet 30 (2000) 367-373
39. Sarter M., and Bruno J.P. Cognitive functions of cortical acetylcholine: toward a unifying hypothesis. Brain Res Rev 23 (1997) 28-46
40. Schalkwyk L.C., Fernandes C., Nash M.W., Kurrikoff K., Vasar E., and Koks S. Interpretation of knockout experiments: the congenic footprint. Genes Brain Behav 6 (2007) 299-303
41. Seeger T., Fedorova I., Zheng F., Miyakawa T., Koustova E., Gomeza J., et al. M2 muscarinic acetylcholine receptor knock-out mice show deficits in behavioral flexibility, working memory, and hippocampal plasticity. J Neurosci 24 (2004) 10117-10127
42. Sibilia M., and Wagner E. Strain-dependent epithelial defects in mice lacking the EGF receptor. Science 269 (1995) 234-238
43. Thomsen M., Woldbye D.P.D., Wortwein G., Fink-Jensen A., Wess J., and Caine S.B. Reduced cocaine self-administration in muscarinic m5 acetylcholine receptor-deficient mice. J Neurosci 25 (2005) 8141-8149
44. Threadgill D., Dlugosz A., Hansen L., Tennenbaum T., Lichti U., Yee D., et al. Targeted disruption of mouse EGF receptor: effect of genetic background on mutant phenotype. Science 269 (1995) 230-234
45. Tzavara E.T., Bymaster F.P., Felder C.C., Wade M., Gomeza J., Wess J., et al. Dysregulated hippocampal acetylcholine neurotransmission and impaired cognition in m2, m4 and m2/m4 muscarinic receptor knockout mice. Mol Psychiatry 8 (2003) 673-679
46. Vannucchi M.G., Scali C., Kopf S.R., Pepeu G., and Casamenti F. Selective muscarinic antagonists differentially affect in vivo acetylcholine release and memory performances of young and aged rats. Neuroscience 79 (1997) 837-846
47. Vilaro M.T., Mengod G., and Palacios J.M. Advances and limitations of the molecular neuroanatomy of cholinergic receptors: the example of multiple muscarinic receptors. Prog Brain Res 98 (1993) 95-101
48. Wess J. Novel insights into muscarinic acetylcholine receptor function using gene targeting technology. Trends Pharmacol Sci 24 (2003) 414-420
49. Wess J. Muscarinic acetylcholine receptor knockout mice: novel phenotypes and clinical implications. Annu Rev Pharmacol Toxicol 44 (2004) 423-450
50. Wess J., Duttaroy A., Zhang W., Gomeza J., Cui Y., Miyakawa T., et al. M-1-M-5 muscarinic receptor knockout mice as novel tools to study the physiological roles of the muscarinic cholinergic system. Receptors Channels 9 (2003) 279-290
51. Whitehouse P.J., Price D.L., Struble R.G., Clark A.W., Coyle J.T., and Delong M.R. Alzheimers-disease and senile dementia-loss of neurons in the basal forebrain. Science 215 (1982) 1237-1239
52. Wolfe B.B., and Yasuda R.P. Development of selective antisera for muscarinic cholinergic receptor subtypes. Ann NY Acad Sci 757 (1995) 186-193
53. Wolfer D.P., Crusio W.E., and Lipp H.-P. Knockout mice: simple solutions to the problems of genetic background and flanking genes. Trends Neurosci 25 (2002) 336-340
54. Yamada M., Miyakawa T., Duttaroy A., Yamanaka A., Moriguchi T., Makita R., et al. Mice lacking the m3 muscarinic acetylcholine receptor are hypophagic and lean. Nature 410 (2001) 207-212
55. Zhang W.L., Basile A.S., Gomeza J., Volpicelli L.A., Levey A.I., and Wess J. Characterization of central inhibitory muscarinic autoreceptors by the use of muscarinic acetylcholine receptor knock-out mice. J Neurosci 22 (2002) 1709-1717